Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The cyclin-dependent kinase inhibitor p16INK4a can induce senescence of human cells, and its loss by deletion, mutation or epigenetic silencing is among the most frequently observed molecular lesions in human cancer. Overlapping reading frames in the INK4A/ARF gene encode p16INK4a and a distinct tumour-suppressor protein, p19ARF (ref. 3). Here we describe the generation and characterization of a p16Ink4a-specific knockout mouse that retains normal p19Arf function. Mice lacking p16Ink4a were born with the expected mendelian distribution and exhibited normal development except for thymic hyperplasia. T cells deficient in p16Ink4a exhibited enhanced mitogenic responsiveness, consistent with the established role of p16Ink4a in constraining cellular proliferation. In contrast to mouse embryo fibroblasts (MEFs) deficient in p19Arf (ref. 4), p16Ink4a-null MEFs possessed normal growth characteristics and remained susceptible to Ras-induced senescence. Compared with wild-type MEFs, p16Ink4a-null MEFs exhibited an increased rate of immortalization, although this rate was less than that observed previously for cells null for Ink4a/Arf, p19Arf or p53 (refs 4, 5). Furthermore, p16Ink4a deficiency was associated with an increased incidence of spontaneous and carcinogen-induced cancers. These data establish that p16Ink4a, along with p19Arf, functions as a tumour suppressor in mice.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p19 Arf and, to a lesser extent, p16 Ink4a have been shown to play a role in the activation of cellular senescence and immortalization on passaging of primary mouse cells in culture (26, 43, 44).”
From Ink4a / Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse (2007) · cites this paper as [43]
In the citing paper
“In vivo (mouse model) studies indicate that p16 suppresses the development of spontaneous cancer (Sharpless et al., 2001).”
From Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors (2005) · cites this paper as Sharpless et al., 2001
In the citing paper
“Mutations in p16 , Rb , ARF and TP53 are frequently found in human cancers, and their tumour-suppressive roles have been confirmed in vivo using genetically modified mouse models [25 -29].”
From The role of cellular senescence and SASP in tumour microenvironment (2023) · cites this paper as [29]
In the citing paper
“Mutations in p16 , Rb , ARF and TP53 are frequently found in human cancers, and their tumour-suppressive roles have been confirmed in vivo using genetically modified mouse models [25 -29].”
From The role of cellular senescence and SASP in tumour microenvironment (2023) · cites this paper as [29]
In the citing paper
“Real-time methylation-specific PCR (MSR) was used to detect the methylation of CpG islands flanking the translation start site of murine p16Ink4a 28,29, revealing a significant increase in methylated CpG sites at the promoter region of p16Ink4a in middle-aged mouse tissues after TAC treatment compared with vehicle controls (Figure 3H).”
From TERT activation targets DNA methylation and multiple aging hallmarks (2024) · cites this paper as [28]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,646
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“exhibit more rapid growth rates and are more readily immortalized in culture, are susceptible to transformation by activated H-Ras alone, and exhibit resistance to Ras-induced senescenc”
BackgroundRole of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585
Self-citationTumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Ouelle, D. E., Zindy, F., Ashmun, R. A., & Sherr, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90214-7 · Cited by 1,485
Herman, J. G., Merlo, A. U., Mao, L., Lapidus, R. G., Issa, J. J., Davidson, N. E., Sidransky, D., & Baylin, S. B. (1995) · PubMed · Cited by 1,341
Efficient in vivo manipulation of mouse genomic sequences at the zygote stage.
Lakso, M., Pichel, J. G., Gorman, J. R., Sauer, B., Okamoto, Y., Lee, E., Alt, F. W., & Westphal, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5860 · Cited by 1,125 · cited 1×
“Mice heterozygous for this mutant allele were crossed with EIIa-Cre mic”
MethodD-type cyclin-dependent kinase activity in mammalian cells.
Matsushime, H., Quelle, D. E., Shurtleff, S. A., Shibuya, M., Sherr, C. J., & Kato, J. Y. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.2066 · Cited by 1,064
Alcorta, D. A., Xiong, Y., Phelps, D., Hannon, G., Beach, D., & Barrett, J. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13742 · Cited by 1,008 · cited 1×
“Accumulation of p16 INK4a correlates with the onset of senescence in human cell”
Background
Cited by
Items 401–500 of 850
Liraglutide, a glucagon-like peptide-1 analog, induce autophagy and senescence in HepG2 cells
Krause, G. C., Lima, K. G., Dias, H. B., da Silva, E. F. G., Haute, G. V., Basso, B. D. S., Gassen, R. B., Marczak, E. S., Nunes, R. S. B., & de Oliveira, J. R. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.05.015 · Cited by 47
Cell Cycle and Cancer: Genetic Analysis of the Role of Cyclin-dependent Kinases
Barbacid, M., Ortega, S., Sotillo, R., Odajima, J., Martín, A., Santamaría, D., Dubus, P. R., & Malumbres, M. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.005 · Cited by 46
Senescent cells at the crossroads of aging, disease, and tissue homeostasis
Kuehnemann, C., & Wiley, C. D. (2023) · Aging Cell · doi:10.1111/acel.13988 · Cited by 51
Ribosomal Proteins Control Tumor Suppressor Pathways in Response to Nucleolar Stress
Lessard, F., Brakier‐Gingras, L., & Ferbeyre, G. (2019) · BioEssays · doi:10.1002/bies.201800183 · Cited by 43
A guide to senolytic intervention in neurodegenerative disease
Lee, S., Wang, E. Y., Steinberg, A. B., Walton, C. C., Chinta, S. J., & Andersen, J. K. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111585 · Cited by 39
p16INK4A and p14ARF tumour suppressors in melanoma: lessons from the mouse
Walker, G. J., & Hayward, N. K. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07271-9 · Cited by 41
Genetic cooperation between p21Cip1 and INK4 inhibitors in cellular senescence and tumor suppression
Quereda, V., Martinalbo, J., Dubus, P. R., Carnero, A., & Malumbres, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210578 · Cited by 44
AP-1 dimers regulate transcription of the p14/p19ARF tumor suppressor gene
Ameyar‐Zazoua, M., Wisniewska, M. B., Bakiri, L., Wagner, E. F., Yaniv, M., & Weitzman, J. B. (2005) · Oncogene · doi:10.1038/sj.onc.1208424 · Cited by 58
DPY30 regulates pathways in cellular senescence through ID protein expression
Simboeck, E., Gutiérrez, A., Cozzuto, L., Beringer, M., Caizzi, L., Keyes, W. M., & Croce, L. D. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.159 · Cited by 40
Canine Mammary Carcinomas: A Comparative Analysis of Altered Gene Expression
Kabir, F. M. L., Alvarez, C. E., & Bird, R. (2015) · Veterinary Sciences · doi:10.3390/vetsci3010001 · Cited by 47
Inhibition of colon tumor progression and angiogenesis by the Ink4a/Arf locus.
Gibson, S. L., Dai, C. Y., Lee, H. W., DePinho, R. A., Gee, M. S., Lee, W. M. F., Furth, E. E., Brensinger, C. M., & Enders, G. H. (2003) · PubMed · Cited by 53
Self-citationMetastasis in an orthotopic murine model of melanoma is independent of RAS/RAF mutation
Rozenberg, G. I., Monahan, K. B., Torrice, C., Bear, J. E., & Sharpless, N. E. (2010) · Melanoma Research · doi:10.1097/cmr.0b013e328336ee17 · Cited by 37
Self-citationBcl-xL as a Modulator of Senescence and Aging
Mas‐Bargues, C., Borrás, C., & Viña, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041527 · Cited by 41
Genetic Mutations of Pancreatic Cancer and Genetically Engineered Mouse Models
Saiki, Y., Jiang, C., Ohmuraya, M., & Furukawa, T. (2021) · Cancers · doi:10.3390/cancers14010071 · Cited by 38
“Mice with constitutive deletion of the P16Ink4a/P19Arf locus did not develop spontaneous pancreatic cancer [91].”
BackgroundZaffaroni, N., Lualdi, S., Villa, R., Bellarosa, D., Cermele, C., Felicetti, P., Rossi, C., Orlandi, L., & Daidone, M. G. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00139-9 · Cited by 41
p16INK4a induces differentiation and apoptosis in erythroid lineage cells
Minami, R., Muta, K., Umemura, T., Motomura, S., Abe, Y., Nishimura, J., & Nawata, H. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00040-7 · Cited by 41
SnoN functions as a tumour suppressor by inducing premature senescence
Pan, D., Zhu, Q., & Luo, K. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.250 · Cited by 44
Pare, R., Shin, J., & Lee, C. S. (2016) · Histopathology · doi:10.1111/his.12948 · Cited by 37
“Hence, loss of p16 in the normal cell promotes hyperplasia, which can lead to an increased risk of tumour development.(15) Induction of cancer formation has been associated with replicative senescence in normal human cells(16) and with p21-induced senescence in tumour cells.”
BackgroundYang, J., Kantrow, S. M., Sai, J., Hawkins, O. E., Boothby, M. R., Ayers, G. D., Young, E. D., Demicco, E. G., Lazar, A. J., Lev, D. C., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0440 · Cited by 43
Negishi, M., Saraya, A., Mochizuki, S., Helin, K., Koseki, H., & Iwama, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012373 · Cited by 36
Biomarkers in the path from cellular senescence to frailty
Zampino, M., Ferrucci, L., & Semba, R. D. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110750 · Cited by 42
Cellular senescence and neurodegeneration
Holloway, K., Neherin, K., Dam, K. U., & Zhang, H. (2023) · Human Genetics · doi:10.1007/s00439-023-02565-x · Cited by 43
Nakade, K., Pan, J., Yamasaki, T., Murata, T., Wasylyk, B., & Yokoyama, K. K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808333200 · Cited by 40
Driving the Cell Cycle to Cancer
Malumbres, M., Hunt, S. L., Sotillo, R., Martín‐Broto, J., Odajima, J., Martín, A., Dubus, P. R., Ortega, S., & Barbacid, M. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0081-0_1 · Cited by 37
Scott, L. A., Vass, J. K., Parkinson, E. K., Gillespie, D. A., Winnie, J. N., & Ozanne, B. W. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.4.1540-1559.2004 · Cited by 41
Cancer Stem Cells, EMT, and Developmental Pathway Activation in Pancreatic Tumors
Hindriksen, S., & Bijlsma, M. F. (2012) · Cancers · doi:10.3390/cancers4040989 · Cited by 42
Dynamics of ARF regulation that control senescence and cancer
Ko, A., Han, S. Y., & Song, J. (2016) · BMB Reports · doi:10.5483/bmbrep.2016.49.11.120 · Cited by 35
Activation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2
Palmero, I., Murga, M., Zubiaga, A. M., & Serrano, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205371 · Cited by 46
Churchman, M. L., Roig, I., Jasin, M., Keeney, S., & Sherr, C. J. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002157 · Cited by 42
Braden, W. A., Lenihan, J. M., Lan, Z., Luce, K. S., Zagorski, W., Bosco, E., Reed, M. F., Cook, J. G., & Knudsen, E. S. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00045-06 · Cited by 35
RetractedKim, H. S., Woolard, K., Lai, C., Bauer, P. O., Maric, D., Song, H., Li, A., Kotliarova, S. E., Zhang, W., & Fine, H. A. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2594 · Cited by 36
Telomere length maintenance in stem cell populations
Allen, N. D., & Baird, D. M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.02.004 · Cited by 36
Disruptive chemicals, senescence and immortality
Carnero, A., Blanco-Aparicio, C., Kondoh, H., Lleonart, M. E., Martinez-Leal, J. F., Mondello, C., Scovassi, A. I., Bisson, W. H., Amedei, A., Roy, R., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv029 · Cited by 29
The genetics of malignant melanoma
Lomas, J., Martín‐Duque, P., Pons, M., & Quintanilla, M. (2008) · Frontiers in bioscience · doi:10.2741/3065 · Cited by 40
KLF10, transforming growth factor-β-inducible early gene 1, acts as a tumor suppressor
Song, K., Kim, D.-J., Lee, J. E., Yun, C., & Lee, W. K. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.02.032 · Cited by 34
Kool, J., Uren, A. G., Martins, C. P., Sie, D., de Ridder, J., Turner, G., van Uitert, M., Matentzoglu, K., Lagcher, W., Krimpenfort, P., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2736 · Cited by 34
Al‐Ansari, M. M., Hendrayani, S., Tulbah, A. M., Al‐Tweigeri, T., Shehata, A. I., & Aboussekhra, A. (2012) · Neoplasia · doi:10.1593/neo.121632 · Cited by 37
The Cell Cycle: Accelerators, Brakes, and Checkpoints
Ivanchuk, S. M., & Rutka, J. T. (2004) · Neurosurgery · doi:10.1227/01.neu.0000109534.28063.5d · Cited by 43
Yang, J., Luan, J., Yu, Y., Li, C., DePinho, R. A., Chin, L., & Richmond, A. J. (2001) · PubMed · Cited by 35
Self-citationLi, Z., Gonzalez, C. L., Wang, B., Zhang, Y., Mejia, O., Katsonis, P., Lichtarge, O., Myers, J. N., El‐Naggar, A. K., & Caulín, C. (2016) · The Journal of Pathology · doi:10.1002/path.4770 · Cited by 37
Hasan, M., Yaguchi, T., Harada, J., Hirano, T., Wadhwa, R., & Kaul, S. C. (2008) · International Journal of Oncology · doi:10.3892/ijo.32.3.663 · Cited by 33
Natarajan, E., Omobono, J. D., Jones, J. C. R., & Rheinwald, J. G. (2005) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1111/j.1087-0024.2005.200415.x · Cited by 35
Targeting senescent cells for the treatment of age-associated diseases
Suda, M., Tchkonia, T., Kirkland, J. L., & Minamino, T. (2024) · The Journal of Biochemistry · doi:10.1093/jb/mvae091 · Cited by 39
Tury, A., Mairet‐Coello, G., & DiCicco-Bloom, E. M. (2012) · Developmental Neurobiology · doi:10.1002/dneu.20999 · Cited by 34
Cholewa, B. D., Ndiaye, M. A., Huang, W., Liu, X., & Ahmad, N. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.10.025 · Cited by 32
Kitajima, S., Miki, T., Takegami, Y., Kido, Y., Noda, M., Hara, E., Shamma, A., & Takahashi, C. (2010) · Oncogene · doi:10.1038/onc.2010.448 · Cited by 37
Wangari‐Talbot, J., & Chen, S. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2012.00330 · Cited by 42
Genetic Mutations Involved in Melanoma: A Summary of Our Current Understanding
High, W. A., & Robinson, W. A. (2007) · Advances in Dermatology · doi:10.1016/j.yadr.2007.07.009 · Cited by 39
Saunderson, E. A., Encabo, H. H., Devis, J., Rouault‐Pierre, K., Piganeau, M., Bell, C. G., Gribben, J. G., Bonnet, D. A., & Ficz, G. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2300224120 · Cited by 38
Sauer, J., Jang, H., Zimmerly, E. M., Kim, K., Liu, Z., Chanson, A., Smith, D. E., Mason, J. B., Friso, S., & Choi, S. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114510000322 · Cited by 35
Li, C., Finkelstein, D., & Sherr, C. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1302184110 · Cited by 33
Diet-Induced Obesity Modulates Epigenetic Responses to Ionizing Radiation in Mice
Varès, G., Wang, B., Ishii‐Ohba, H., Nenoi, M., & Nakajima, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106277 · Cited by 33
p16Ink4a Prevents the Activation of Aged Quiescent Dentate Gyrus Stem Cells by Physical Exercise
Micheli, L., D’Andrea, G., Ceccarelli, M., Ferri, A., Scardigli, R., & Tirone, F. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00010 · Cited by 38
A Major Functional Difference between the Mouse and Human ARF Tumor Suppressor Proteins
Wadhwa, R., Sugihara, T., Hasan, M. K., Taira, K., Reddel, R. R., & Kaul, S. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203222200 · Cited by 35
The Role of CDKs and CDKIs in Murine Development
Campbell, G. J., Hands, E. L., & de Pette, M. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155343 · Cited by 37
González‐Gil, C., Ribera, J., Ribera, J., & Genescà, E. (2021) · Genes · doi:10.3390/genes12010079 · Cited by 33
The CDK inhibitors: potential targets for therapeutic stem cell manipulations?
Boyer, M. J., & Cheng, T. (2007) · Gene Therapy · doi:10.1038/sj.gt.3303064 · Cited by 36
Tumor suppressor mechanisms in immune aging
Liu, Y., & Sharpless, N. E. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.05.011 · Cited by 30
Self-citationRestoration of protein synthesis in pancreatic cancer cells by trans-splicing ribozymes
Kastanos, E. K., Hjiantoniou, E., & Phylactou, L. A. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.203 · Cited by 30
Aberrant expression of p14 ARF in human cancers: A new biomarker?
Inoue, K., & Fry, E. A. (2018) · Tumor and Microenvironment · doi:10.4103/tme.tme_24_17 · Cited by 33
Aveyard, J. S., & Knowles, M. A. (2004) · Journal of Molecular Diagnostics · doi:10.1016/s1525-1578(10)60532-6 · Cited by 33
David-Pfeuty, T. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.08.008 · Cited by 37
The significance of the senescence pathway in breast cancer progression
Pare, R. B., Yang, T., Shin, J., & Lee, C. S. (2013) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2012-201081 · Cited by 34
Silva, G. P. D. L., & Aboussekhra, A. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22299 · Cited by 31
Mechanisms That Limit the In Vitro Proliferative Potential of Human CD8+ T Lymphocytes
Migliaccio, M., Raj, K., Menzel, O., & Rufer, N. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3335 · Cited by 29
Zhang, H., Lawson, W. E., Polosukhin, V. V., Pozzi, A., Blackwell, T. S., Litingtung, Y., & Chiang, C. C. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070226 · Cited by 30
Modeling gene–environment interactions in malignant melanoma
Merlino, G. T., & Noonan, F. P. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00006-6 · Cited by 32
p53-independent apoptosis is induced by the p19ARF tumor suppressor
Tsuji, K., Mizumoto, K., Sudo, H., Kouyama, K., Ogata, E., & Matsuoka, M. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00723-4 · Cited by 35
E4F1 deficiency results in oxidative stress–mediated cell death of leukemic cells
Hatchi, E., Rodier, G., Lacroix, M., Caramel, J., Kirsh, O., Jacquet, C., Schrepfer, E., Lagarrigue, S., Linares, L. K., Lledo, G., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20101995 · Cited by 35
Naemura, M., Tsunoda, T., Inoue, Y., Okamoto, H., Shirasawa, S., & Kotake, Y. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2618-5 · Cited by 29
Al‐Khalaf, H. H., & Aboussekhra, A. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22564 · Cited by 32
Korpershoek, E., Pacák, K., & Martiniova, L. (2012) · Endocrine Pathology · doi:10.1007/s12022-012-9194-y · Cited by 29
Genetic Modeling of Glioma Formation in Mice
Begemann, M., Fuller, G. N., & Holland, E. C. (2002) · Brain Pathology · doi:10.1111/j.1750-3639.2002.tb00428.x · Cited by 28
Lagresle, C., Gardie, B., Eyquem, S., Fasseu, M., Vieville, J.-C., Pla, M., Sigaux, F., & Bories, J.-C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.5.2325 · Cited by 28
Potential of Mesenchymal Stem Cells in the Rejuvenation of the Aging Immune System
Yeo, G. E. C., Ng, M. H., Nordin, F., & Law, J. X. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115749 · Cited by 30
Neural stem cells, tumour stem cells and brain tumours: Dangerous relationships?
SUTTER, R., Yadırgı, G., & Marino, S. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.07.006 · Cited by 33
Mammalian Interphase Cdks: Dispensable Master Regulators of the Cell Cycle
Enders, G. H. (2012) · Genes & Cancer · doi:10.1177/1947601913479799 · Cited by 30
The tumor suppressor p16Ink4a regulates T lymphocyte survival
Bianchi, T., Rufer, N., MacDonald, H. R., & Migliaccio, M. (2006) · Oncogene · doi:10.1038/sj.onc.1209437 · Cited by 27
p16Ink4a or p19Arf loss contributes to Tal1-induced leukemogenesis in mice
Calvo, J. A., Draheim, K., Bhasin, M., & Kelliher, M. A. (2005) · Oncogene · doi:10.1038/sj.onc.1209326 · Cited by 35
Perturbations of the Ink4a/Arf gene locus in aflatoxin B1-induced mouse lung tumors
Tam, A. S. M., Devereux, T. R., Patel, A. C., Foley, J. F., Maronpot, R. R., & Massey, T. E. (2003) · Carcinogenesis · doi:10.1093/carcin/24.1.121 · Cited by 28
Monoclonal Antibodies to the Mouse p19 Arf Tumor Suppressor Protein
Bertwistle, D., Zindy, F., Sherr, C. J., & Roussel, M. F. (2004) · Hybridoma and Hybridomics · doi:10.1089/hyb.2004.23.293 · Cited by 30
An essential role for Ink4 and Cip/Kip cell-cycle inhibitors in preventing replicative stress
Quereda, V., Porlan, E., Cañamero, M., Dubus, P. R., & Malumbres, M. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.112 · Cited by 36
Molecular Mechanisms to Target Cellular Senescence in Hepatocellular Carcinoma
Mittermeier, C., Konopa, A., & Muehlich, S. (2020) · Cells · doi:10.3390/cells9122540 · Cited by 31
Zhu, X., LeBoeuf, M. R., Liu, F., Grachtchouk, M. A., Seykora, J. T., Morrisey, E. E., Dlugosz, A. A., & Millar, S. E. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2021.05.026 · Cited by 28
Safwan‐Zaiter, H., Wagner, N., Michiels, J., & Wagner, K. (2022) · Cells · doi:10.3390/cells11030541 · Cited by 28
The Nucleolus and Ribosomal Genes in Aging and Senescence
Hein, N., Sanij, E., Quin, J. E., Katherine, M., Ganley, A. R. D., & Ross, D. (2012) · InTech eBooks · doi:10.5772/34581 · Cited by 31
Regulation of cellular senescence by Rb2/p130
Helmbold, H., Deppert, W., & Bohn, W. (2006) · Oncogene · doi:10.1038/sj.onc.1209613 · Cited by 33
Models and mechanisms in malignant melanoma
Benjamin, C. L., Melnikova, V. O., & Ananthaswamy, H. N. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20353 · Cited by 33
The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
D’Amico, M., Wu, K., Vizio, D. D., Reutens, A. T., Stahl, M. C., Fu, M., Albanese, C., Russell, R. G., Muller, W. J., White, M. A., et al. (2003) · PubMed · Cited by 28
Self-citationDamo, L. A., Snyder, P. W., & Franklin, D. S. (2004) · Molecular Carcinogenesis · doi:10.1002/mc.20068 · Cited by 31
Yang, Y., Wang, W., Cleaves, R., ZAHURAK, M. L., Cheng, L., Civin, C. I., & Friedman, A. D. (2002) · PubMed · Cited by 31
The lymphoma-associated NPM-ALK oncogene elicits a p16INK4a/pRb-dependent tumor-suppressive pathway
Martinelli, P., Bonetti, P., Sironi, C., Pruneri, G., Fumagalli, C., Raviele, P. R., Volorio, S., Pileri, S. A., Chiarle, R., McDuff, F. K. E., et al. (2011) · Blood · doi:10.1182/blood-2010-08-301135 · Cited by 28
PDGFRβ is an essential therapeutic target for BRCA1-deficient mammary tumors
Bai, F., Liu, S., Liu, X., Hollern, D. P., Scott, A., Wang, C., Zhang, L., Fan, C., Fu, L., Perou, C. M., et al. (2021) · Breast Cancer Research · doi:10.1186/s13058-021-01387-x · Cited by 25
Woods, J. M., Kłosowska-Buryło, K., Spoden, D. J., Stumbo, N. G., Paige, D. J., Scatizzi, J. C., Volin, M. V., Rao, M. S., & Perlman, H. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1999 · Cited by 24
Epimorphic regeneration in mice is p53-independent
Arthur, L. M., Demarest, R. M., Clark, L. D., Gourevitch, D., Bedelbaeva, K., Anderson, R., Snyder, A. R., Capobianco, A. J., Lieberman, P. M., Feigenbaum, L., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.18.13119 · Cited by 26
p19Ink4d Is a Tumor Suppressor and Controls Pituitary Anterior Lobe Cell Proliferation
Bai, F., Chan, H. L., Smith, M. D., Kiyokawa, H., & Pei, X. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01363-13 · Cited by 27
INK4a/ARF Expression Impairs Neurogenesis in the Brain of Irradiated Mice
Lê, O., Palacio, L., Bernier, G., Batinic̈‐Haberle, I., Hickson, G. R. X., & Beausejour, C. M. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.03.025 · Cited by 27
Expression of genes involved in the regulation of p16 in psoriatic involved skin
Mark, E. B., Jonsson, M., Asp, J., Wennberg, A., Mölne, L., & Lindahl, A. H. (2006) · Archives of Dermatological Research · doi:10.1007/s00403-006-0649-1 · Cited by 26
Aguirre‐Hernández, J., Milne, B. S., Queen, C., O´Brien, P. C. M., Hoather, T. M., Haugland, S., Ferguson-Smith, M. A., Dobson, J. M., & Sargan, D. R. (2009) · BMC Veterinary Research · doi:10.1186/1746-6148-5-27 · Cited by 31
Owens, B. M., Hawley, T. S., Spain, L. M., Kerkel, K. A., & Hawley, R. G. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05850.x · Cited by 33
Metadata
- Authors
- Sharpless, N. E., Bardeesy, N., Lee, K.-H., Carrasco, D., Castrillon, D. H., Aguirre, A. J., Wu, E. A., Horner, J. W., & DePinho, R. A.
- Affiliations
- Harvard University (US)
- Corresponding author
- DePinho, Ronald A.
- Venue
- Nature
- Published
- 2001-09
- Volume
- 413
- Issue
- 6851
- Pages
- 86-91
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2017235640
- Cited by
- 848
- References
- 30
- Citations by year
- 2026: 7 · 2025: 2 · 2024: 19 · 2023: 26 · 2022: 15 · 2021: 36 · 2020: 17 · 2019: 17 · 2018: 17 · 2017: 26 · 2016: 17 · 2015: 29 · 2014: 32 · 2013: 34 · 2012: 34
- FWCI
- 29.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- KWF Kankerbestrijding
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- p16INK4a, p19ARF, tumour suppressor, senescence, carcinogenesis, knockout mice, thymic hyperplasia, T cell proliferation, Ras-induced senescence, cell immortalization, carcinogen-induced cancer, p53
- MeSH terms
- Animals, Carcinogens, Cell Division, Cell Transformation, Neoplastic, Cells, Cultured, Embryo, Mammalian, Female, Fibroblasts, Male, Neoplasms, Proteins, T-Lymphocytes, Thymus Gland, Urethane, 9,10-Dimethyl-1,2-benzanthracene, Gene Deletion, Mice, Knockout, Gene Targeting, Genes, p16, Genetic Predisposition to Disease, Tumor Suppressor Protein p14ARF, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.